XML 87 R44.htm IDEA: XBRL DOCUMENT v3.25.0.1
Share-Based Payment (Tables)
 12 Months Ended
Dec. 31, 2024
Share-Based Payment [Abstract]  
Schedule of Measure the Fair Value of the Option at Grant Date

The following inputs were used to measure the fair value of the option at grant date:

  

     March 24, 2022  January 22, 2024  February 5, 2024
(i) Expected volatility  52%  144.83%  143.98%
(ii) Dividend rate  0%  0%  0%
(iii) Expected term (vesting period)  Three years  Three years  Three years
(iv) Contractual life  Ten years  Ten years  Ten years
(v) Free risk rate  2.79%-2.80%  4.03%-4.07%  4.16%
Schedule of Options to Services Providers and Advisers Outstanding

The options to services providers and advisers outstanding as December 31, 2024, 2023 and 2022 were as follows:

 

   Year ended
December 31, 2024		   Year ended
December 31, 2023		   Year ended
December 31, 2022		 
   Number of
options		   Weighted
average
Exercise
price NIS		   Number of
options		   Weighted
average
Exercise
price NIS		   Number of
options		   Weighted
average
Exercise
price NIS		 
                         
Outstanding at beginning of year   105,111    4.085    114,512    3.058    87,833    0.37 
Reclassified to employees and directors   -    -    -    -    -    - 
Granted   80,000    3.779    -    -    29,400    10.84 
Exercised   -    -    9,401    0.367    (2,721)   0.37 
Forfeited   -    -    -    -    -    - 
Options outstanding   185,111    3.359    105,111    4.085    114,512    3.058 
Options exercisable   162,154    3.251    94,242    3.267    82,257    0.37 
Share-based payment expenses  $66        $19        $54      

The options to employees and directors outstanding as of December 31, 2024, 2023 and 2022 were as follows:

 

   Year ended
December 31, 2024		   Year ended
December 31, 2023		   Year ended
December 31, 2022		 
   Number of
options		   Weighted
average
Exercise
price NIS		   Number of
options		   Weighted
average
Exercise
price NIS		   Number of
options		   Weighted
average
Exercise
price NIS		 
                         
Outstanding at beginning of year   357,689    0.37    386,260    0.37    448,120    0.37 
Granted   30,000    3.56    -    -         - 
Exercised   19,048    0.37         0.37    4,309    0.37 
Forfeited   -    -    28,571    0.37    57,551    0.37 
Options outstanding   368,641    0.70    357,689    0.37    386,260    0.37 
Options exercisable   338,641    0.45    350,131    0.37    342,757    0.37 
Share-based payment expenses  $17        $47    -   $174    - 
Schedule of RSUs to Services Providers and Advisers Outstanding

The RSUs to services providers and advisers outstanding as of December 31, 2024, 2023 and 2022 were as follows:

 

   Year ended
December 31,
2024		   Year ended
December 31,
2023		   Year ended
December 31,
2022		 
   Number of
RSUs		   Number of
RSUs		   Number of
RSUs		 
Outstanding at beginning of year   7,433    18,266    10,000 
Granted   -    -    22,500 
Vested   7,433    10,833    14,234 
RSUs outstanding   -    7,433    18,266 
RSU’s Vested   32,500    25,067    14,234 
Share-based payment expenses  $1   $9   $33 

The RSUs to employees and directors outstanding as of December 31, 2024, 2023 and 2022 were as follows:

 

   Year ended
December 31,
2024		   Year ended
December 31,
2023		   Year ended
December 31,
2022		 
   Number of
RSUs		   Number of
RSUs		   Number of
RSUs		 
Outstanding at beginning of year   445,140    1,727,842    2,002,587 
Granted   2,687,000    -    1,016,854 
Forfeited   25,836    67,087    65,626 
Vested   587,508    1,215,615    1,225,973 
RSUs outstanding   2,518,796    445,140    1,727,842 
RSU’s Vested   3,684,697    3,097,189    1,881,574 
Share-based payment expenses  $1,683   $1,352   $4,618